Pharmacodynamic: under the influence of alpha-adrenoblockers (dihydroergotamine, etc.), it is possible to reduce the antianginal effect of nitrosorbide (excessive decrease in blood pressure and coronary perfusion as a consequence).
The combination of amiodarone and other medications, such as,
propranolol, blockers of "slow" calcium channels (
verapamil,
nifedipine and others) and nitrosorbide is rational for the treatment of coronary heart disease.
The combined use of acetylsalicylic acid and nitrosorbide improves coronary circulation.
With the combined use of nitrosorbide with antihypertensive. drugs, vasodilators, antipsychotic drugs (antipsychotics), tricyclic antidepressants, novocainamide, ethanol, quinidine, beta-adrenoblockers, blockers of "slow" calcium channels and dihydroergotamine may increase the severity of blood pressure lowering.
When combined use of nitrosorbide with m-holinoblokatorami (
atropine and others) increases the likelihood of increased intraocular pressure.With simultaneous admission with sildenafil (Viagra), a marked decrease in blood pressure is possible.
Pharmacokinetic: adsorbents, astringents and enveloping agents reduce the absorption of nitrosorbide in the gastrointestinal tract.